Immunome stock performance snapshot Immunome (IMNM) has drawn fresh attention after recent share price swings, with the stock up about 1.5% over the past day but showing a roughly 14% decline over the ...
The grey market premium for the mainboard IPO has declined in the last few days, indicating a discounted or flat listing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results